Friday, October 21, 2011: 9:30 AM-12:00 PM
4.1
Psychiatric Outcomes of Childhood Speech/Language Impairment: Converging Mental Health Trajectories in Early Adulthood
Joseph H. Beitchman, M.D.
Centre of Addiction and Mental Health and University of Toronto, Toronto, ON
Elizabeth Brownlie, Ph.D.
Centre for Addiction and Mental Health, Toronto, ON
Shelly-Anne Li, B.S.
Centre for Addiction and Mental Health, Toronto, ON
Nadia Mirdha
Centre for Addiction and Mental Health, Toronto, ON
Debbie C. Schachter, M.D., FRCPC
Centre for Addiction and Mental Health and University of Toronto, Toronto, ON
Eva Graham, B.A.
Centre for Addiction and Mental Health, Toronto, ON
4.2
Overweight Status and Nutrition in Children with Disruptive Behavior Disorders
Wei Shyan Lim, M.S.
Duke-National University of Singapore Graduate Medical School, Singapore Singapore
Yoon Phaik Ooi, Ph.D.
Institute of Mental Health, Singapore Singapore
Caroline Widiaty, M.D.
Institute of Mental Health, Child Guidance Clinic, Singapore Singapore
Choon Guan Lim, M.D.
Institute for Mental Health, Singapore Singapore
Delia H.Y. Yang, B.S.
Child Guidance Clinic, Institute of Mental Health Singapore, Singapore Singapore
Michael J. Meaney, Ph.D.
McGill University, Montreal, QC
Daniel S.S. Fung, M.D.
Institute of Mental Health, Singapore Singapore
Yuhuan Xie, M.D.
Institute of Mental Health, Singapore Singapore
4.3
Can Severity of the Aggression/Anxiety-Depression/Attention (A-A-A) CBCL Profiles Discriminate Between Deficient Emotional Self Regulation and Bipolar Symptoms?: A Controlled Study in Youth with ADHD
Joseph Biederman, M.D.
Massachusetts General Hospital, Boston, MA
Carter R. Petty, M.A.
Massachusetts General Hospital, Boston, MA
Thomas J. Spencer, M.D.
Massachusetts General Hospital, Boston, MA
Stephen V. Faraone, Ph.D.
State University of New York Upstate Medical University, Syracuse, NY
Craig Surman, M.D.
Massachusetts General Hospital, Watertown, MA
Janet Wozniak, M.D.
Massachusetts General Hospital, Cambridge, MA
4.5
The Effect of a 12-Week School-Based Exercise Program on Depression and Inattention in Overweight Children: A Pilot Study
GyungMee Kim, M.D.
Haeundae Paik Hospital, Inje University, Busan South Korea
YongHee Hong, M.D.
SoonChunHyang Hospital, SoonChunHyang University, Seoul South Korea
JinKyung Park, Ph.D.
Korean Maternal Health Care Center, Soonchunhyang University Hospital, Seoul South Korea
4.6
Private-Public Partnership: A Cost Effective Solution to Clinical Support in the Schools
Karen T. Cammuso, Ph.D.
Alpert School of Medicine, Brown University, East Providence, RI
Gregory K. Fritz, M.D.
Bradley Hasbro Research Center, Providence, RI
John Peterson, M.B.A.
Bradley Hospital, East Providence, RI
Dale Radka, M.D.
Alpert School of Medicine, Brown University, East Providence, RI
Anne S. Walters, Ph.D.
Alpert School of Medicine, Brown University, East Providence, RI
4.8
A Comparison of Children's Attention and Cognitive Function Across Noise Conditions: A Randomized Controlled Study
Soo-Young Bhang, M.D., M.P.H.
Ulsan University Hospital, Ulsan South Korea
Jiho Lee, M.D., Ph.D.
Ulsan University Hospital, Ulsan South Korea
Jangmyung Lee, Ph.D.
Ulsan University, Ulsan South Korea
Changsun Sim, M.D.
University of Ulsan, College of Medicine, Ulsan University Hospital, Ulsan South Korea
Jae-Kook Yoon, M.D.
Ulsan University Hospital, Ulsan South Korea
Joohyun Sung, M.D.
Ulsan University Hospital, Ulsan South Korea
4.9
Distinctive Role of Processing Speed on Arithmetic Low-Achievement in ADHD
Behnoosh Dashti, M.D., M.P.H.
The Hospital for Sick Children, Toronto, ON
Donald J. Mabbott, Ph.D.
The Hospital for Sick Children, Toronto, ON
Abel Ickowicz, M.D., FRCPC
The Hospital for Sick Children, Toronto, ON
4.10
Efficacy and Safety of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase 3, Randomized, Double-Blind, Multicenter, Parallel-Group, Placebo- and Active-Controlled, Dose-Optimized Study in Europe
David R. Coghill, M.D., F.R.C.Psych., M.B.Ch.B.
Centre for Neuroscience, Dundee Scotland
Tobias Banaschewski, M.D., Ph.D.
Department of Child and Adolescent Psychiatry and Psychotherapy, Mannheim Germany
Michel L. Lecendreux, M.D.
Pediatric Sleep Center, Paris France
Cesar A. Soutullo, M.D., Ph.D.
University of Navarra Clinic, Pamplona Spain
Mats Johnson, M.D.
Child Neuropsychiatry Unit, Göteborg Sweden
Colleen S. Anderson, B.A.
Shire Development Inc, Wayne, PA
Richard Civil, M.D.
Shire Pharmaceuticals Inc, Wayne, PA
C. Nicholas Higgins, B.S.
Shire Development Inc, Wayne, PA
Andrew Lyne, M.S.C., C.Stat.
Shire Pharmaceuticals Inc, Basingstoke United Kingdom
Liza A. Squires, M.D.
Shire Pharmaceuticals Inc, Wayne, PA
4.11
Predictors of Persistence in Girls with ADHD: Results From a Large, 11-Year Controlled Follow-up Study
Joseph Biederman, M.D.
Massachusetts General Hospital, Boston, MA
Carter R. Petty, M.A.
Massachusetts General Hospital, Boston, MA
Nora Friedman, M.D.
Massachusetts General Hospital, Boston, MA
Katherine B. O'Connor, B.A.
Massachusetts General Hospital, Boston, MA
Laran Hyder, B.A.
Massachusetts General Hospital, Boston, MA
Stephen V. Faraone, Ph.D.
State University of New York Upstate Medical University, Syracuse, NY
4.12
Does Exposure to Maternal Smoking During Pregnancy Affect the Clinical Features of ADHD? Results From a Controlled Study
Joseph Biederman, M.D.
Massachusetts General Hospital, Boston, MA
Carter R. Petty, M.A.
Massachusetts General Hospital, Boston, MA
Pradeep Bhide, Ph.D.
Massachusetts General Hospital; Harvard Medical School, Charlestown, MA
K. Yvonne Woodworth, B.A.
Massachusetts General Hospital, Boston, MA
Nora Friedman, M.D.
Massachusetts General Hospital, Boston, MA
Stephen V. Faraone, Ph.D.
State University of New York Upstate Medical University, Syracuse, NY
4.13
Working Memory Training in College Students with ADHD/Learning Disabilities
Rachel J. Gropper, M.A.
Ontario Institute for Studies in Education, University of Toronto, Toronto, ON
Rosemary Tannock, Ph.D.
Ontario Institute for Studies in Education, University of Toronto, The Hospital for Sick Children, Toronto, ON
4.14
Effectiveness of Cognitive Behavior Treatment for Medicated Adults with Residual ADHD Symptoms: A Randomized Controlled Study From Iceland
Brynjar Emilsson, M.S.C.
Landspítali Hospital, Reykjavik Iceland
Gisli Gudjonsson, Ph.D.
Kings College London, London United Kingdom
Jon F. Sigurdsson, Ph.D.
Landspítali Hospital, Reykjavik Iceland
Gisli Baldursson, M.D.
Landspítali Hospital, Reykjavik Iceland
Halldora Olafsdottir, M.D.
Landspítali Hospital, Reykjavik Iceland
Emil Einarsson, M.S.C.
Landspítali Hospital, Reykjavik Iceland
Susan J. Young, Ph.D.
Institute of Psychiatry, Kings College London, London United Kingdom
4.16
Academic Performance and IQ Subtest Differences in Children by ADHD Subtype: A Community-Based Study
Steven P. Cuffe, M.D.
University of Florida College of Medicine-Jacksonville, Jacksonville, FL
Lorie L. James, M.P.H.
University of South Carolina, Arnold School of Public Health, Columbia, SC
Joseph R. Holbrook, M.P.H.
University of South Carolina, Arnold School of Public Health, Columbia, SC
Jennifer C. Gander, B.S.
University of South Carolina, Arnold School of Public Health, Columbia, SC
Kristina A. Storck, B.A.
University of South Carolina, Arnold School of Public Health, Columbia, SC
Lindsay C. Robinson, B.S.
University of South Carolina, Arnold School of Public Health, Columbia, SC
Robert E. McKeown, Ph.D.
University of South Carolina, Columbia, SC
4.17
Obesity in Adults with Childhood ADHD: A 33-Year Controlled, Prospective Follow-up
Samuele Cortese, M.D., Ph.D.
Institute for Pediatric Neuroscience, New York, NY
Maria A. Ramos Olazagasti, Ph.D.
Phyllis Green and Randolph Cowen Institute for Pediatric Neuroscience, New York, NY
Rachel G. Klein, Ph.D.
Anita Saltz Institute for Anxiety and Mood Disorders, New York, NY
F. Xavier Castellanos, M.D.
New York University Langone Medical Center, New York, NY
Salvatore Mannuzza, Ph.D.
Anita Saltz Institute for Anxiety and Mood Disorders, New York, NY
4.18
How to Switch From Stimulants to Atomoxetine in ADHD Patients: Fast vs. Slow Switching Approaches
Esther Cardo, Ph.D.
Neuropediatric Hospital Son Llatzer, University of Balearic Island, Palma de Mallorca Spain
Vibeke Porsdal, M.D., Ph.D.
Eli Lilly Denmark A/S, Lyngby Denmark
Joaquin Fuentes, M.D.
Policlinica Gipuzkoa, San Sebastian Spain
Christopher Steer, M.B.Ch.B.
Victoria Hospital, Fife United Kingdom
Deborah Quail
Lilly UK, Windlesham United Kingdom
Alonso G. Montoya, M.D.
Lilly Lboaratories Spain, Alcobendas Spain
Ernie Anand, M.D.
Lilly UK, Windlesham United Kingdom
Rodrigo Escobar, M.D.
Lilly Research Laboratories Japan, Kobe Japan
4.19
Participant-Perceived Quality of Life in a Long-Term, Open-Label Trial of Lisdexamfetamine Dimesylate in Adolescents with ADHD
Ann C. Childress, M.D.
Center for Psychiatry and Behavioral Medicine, Las Vegas, NV
Andrew Cutler, M.D.
Florida Clinical Research Center, LLC, Bradenton, FL
Keith Saylor, Ph.D.
NeuroScience, Inc., Herndon, VA
Maria Gasior, M.D., Ph.D.
Shire Pharmaceuticals Inc., Wayne, PA
Mohamed Hamdani, M.S.
Shire Development Inc., Wane, PA
M. Celeste Ferreira-Cornwell, Ph.D.
Shire Development Inc., Wayne, PA
Robert L. Findling, M.D.
University Hospitals Case Medical Center, Cleveland, OH
4.20
The Attentional Network Differences in Individuals with ADHD
Kim Saliba, M.S.C.
Centre for Addiction and Mental Health, Toronto, ON
Umesh Jain, M.D., FRCPC, Ph.D.
Centre for Addiction and Mental Health, Toronto, ON
Rosemary Tannock, Ph.D.
Ontario Institute for Studies in Education, University of Toronto, The Hospital for Sick Children, Toronto, ON
4.21
Atomoxetine Dosing Strategies and Tolerability
Linda Wietecha, M.S., R.N.
Eli Lilly and Company, Indianapolis, IN
Dustin D. Ruff, Ph.D.
Eli Lilly and Company, Indianapolis, IN
Albert John Allen, M.D., Ph.D.
Eli Lilly and Company, Indianapolis, IN
Laurence L. Greenhill, M.D.
New York State Psychiatric Institute, New York, NY
Jeffrey Newcorn, M.D.
Mount Sinai Medical Center, New York, NY
4.22
Effects of Clonidine Hydrochloride on Oppositional Features in Children and Adolescents with ADHD
Raul R. Silva, M.D.
Academic Behavioral Center, Cresskill, NJ
Dinohra M. Munoz-Silva, M.D.
, Tenafly, NJ
Rafael Muniz, M.D.
Shionogi Pharma, Inc. (formerly Sciele Pharmaceuticals), Florham Park, NJ
4.23
The Role of Family Environment in ADHD Outcome
Wendy S. Sharp, M.S.W.
National Institute of Mental Health, Bethesda, MD
Meaghan Malek, B.A.
National Institute of Mental Health, Bethesda, MD
Mary Gilliam, B.A.
National Institute of Mental Health, Bethesda, MD
Deanna Greenstein, Ph.D.
National Institute of Mental Health, Bethesda, MD
Wallace Philip Shaw, M.D.
National Institute of Mental Health, Washington, DC
4.24
Comparison of Treatment Adherence in Patients Initiated on Lisdexamfetamine Dimesylate (LDX) Vs. Other Medications for the Treatment of ADHD: A Retrospective Study
Juliana Setyawan, M.S., Pharm.D.
Shire Pharmaceuticals Inc, Wayne, PA
Paul Hodgkins, Ph.D.
Shire Pharmaceuticals Inc., Wayne, PA
Eric Q. Wu, Ph.D.
Analysis Group Inc., Boston, MA
Annie Guerin, M.S.
Analysis Group Inc., Boston, MA
Genevieve Gauthier, M.S.
Analysis Group Inc., Boston, MA
Martin Cloutier, M.S.
Analysis Group Inc., Boston, MA
M. Haim Erder, Ph.D.
Shire Pharmaceuticals Inc., Wayne, PA
4.26
Psychometric Properties of the ADHD Strength-Based Interview for Parents
Philippe Robaey, M.D., FRCPC, Ph.D.
Children's Hospital of Eastern Ontario; University of Ottawa; Université de Montréal, Ottawa, ON
Russell J. Schachar, M.D., FRCPC
The Hospital for Sick Children, Toronto, ON
Nadine Forget-Dubois, Ph.D.
Université Laval, Québec, QC
Ginette Dionne, Ph.D.
Université Laval, Québec, QC
Michel Boivin, Ph.D.
Université Laval, Québec, QC
4.27
How Do Children See Themselves? Quality of Life for Children with ADHD and Learning Disabilities
Kamelia Mirdamadi, B.S.
University of Toronto, Toronto, ON
Emanuela Yeung, B.S.
The Hospital for Sick Children, Toronto, ON
Alice Charach, M.D., M.S.
University of Toronto, Toronto, ON
4.28
Persistence of Cognitive Deficits Point to Underlying Genetic Risk in ADHD
Tara McAuley, Ph.D.
The Hospital for Sick Children, Toronto, ON
Jennifer Crosbie, Ph.D.
The Hospital for Sick Children, Toronto, ON
Alice Charach, M.D., M.S.
University of Toronto, Toronto, ON
Troy Harris Climans
University of Toronto, Toronto, ON
Russell J. Schachar, M.D., FRCPC
The Hospital for Sick Children, Toronto, ON
4.29
A Pharmacokinetic and Safety Evaluation of Single Oral Doses of Eszopiclone in Pediatric Subjects From 6 to 17 Years of Age with ADHD and Insomnia
Gary Maier, Ph.D.
Sunovion Pharmaceuticals, Inc., Marlborough, MA
Jeffrey Blumer, M.D.
University Hospitals Rainbow Babies & Children's Hospital, Cleveland, OH
Brigitte Robertson, M.D.
Sunovion Pharmcaeuticals, Inc., Marlborough, MA
Qiang Lu
Cognigen Corporation, Buffalo, NY
Jacqueline Zummo, Ph.D.
Sunovion Pharmaceuticals, Inc., Marlborough, MA
Elizabeth Ludwig
Cognigen Corporation, Buffalo, NY
4.32
A Comparison of Observational and Self-Report Measures to Assess the Efficacy of Two Interventions for Parents of ADHD Children
Julie Lessard, Ph.D.
Université Laval, Québec, QC
Sylvie Normandeau, Ph.D.
Université de Montréal, Montréal, QC
4.33
A Fixed-Dose, Randomized, Double-Blind, Placebo-Controlled Study of LY2216684 in Pediatric Patients with ADHD
Daniel Lin, Ph.D.
Eli Lilly and Company, Indianapolis, IN
Christopher J. Kratochvil, M.D.
University of Nebraska Medical Center, Omaha, NE
Wen Xu, Ph.D.
Eli Lilly and Company, Indianapolis, IN
Ling Jin
Eli Lilly and Company, Indianapolis, IN
Deborah D'Souza
i3 Statprobe, Indianapolis, IN
Albert John Allen, M.D., Ph.D.
Eli Lilly and Company, Indianapolis, IN
4.34
Effect of Adult ADHD on Posttraumatic Stress Disorder in Korean Conscripts
Cheol-Soon Lee, M.D.
Gyeongsang National University Hospital, Jinju South Korea
4.35
Norepinephrine Genes Predict Response Time Variability and Methylphenidate-Induced Changes in Neuropsychological Function in ADHD
Jae-Won Kim, M.D., Ph.D.
Seoul National University Hospital, Seoul South Korea
4.36
Impact of Mental Health Comorbidities on Healthcare Utilization and Costs in a Large Managed Care Adult ADHD Population
Aniket A. Kawatkar, M.S., Ph.D.
Southern California Permanente Medical Group, Pasadena, CA
Tara K. Knight, Ph.D.
University of Southern California, Los Angeles, CA
Paul Hodgkins, Ph.D.
Shire Pharmaceuticals Inc., Wayne, PA
Vanja Sikirica, M.P.H., Pharm.D.
Shire Pharmaceuticals Inc., Wayne, PA
Robert A. Moss
Southern California Permanente Medical Group, Pasadena, CA
M. Haim Erder, Ph.D.
Shire Pharmaceuticals Inc., Wayne, PA
Michael B. Nichol
University of Southern California, Los Angeles, CA
4.37
The Long-Term Effect of Methylphenidate on Brain Function of ADHD Children After Wash-Out Period
Ayaka Ishii-Takahashi, M.D.
Tokyo University, Tokyo Japan
4.38
Safety and Efficacy of Lisdexamfetamine Dimesylate in Adults with ADHD and Self-Reported Impairments in Executive Function Behaviors
Richard Weisler, M.D.
Duke University Medical Center; University of North Carolina at Chapel Hill, Raleigh, NC
Bryan Dirks, M.D.
Shire Development Inc., Wayne, PA
Patrick F. Deas, B.S.
Shire Development Inc., Wayne, PA
Aparna Raychaudhuri, Ph.D.
Shire Development Inc., Wayne, PA
Matthew Dauphin, M.S.
Shire Development Inc., Wayne, PA
Robert Lasser, M.D.
Shire Development Inc., Wayne, PA
Lenard Adler, M.D.
New York University School of Medicine; VA New York Harbor Healthcare System, New York, NY
4.39
Childhood Precursors of Adult Impairment and Comorbidity in ADHD
Matthew J. Warhol, B.A.
Teachers College, Columbia University, New York, NY
Mary Solanto, Ph.D.
Mount Sinai Medical Center, New York, NY
James Schmeidler, Ph.D.
Mount Sinai Medical Center, New York, NY
David Marks, Ph.D.
Mount Sinai Medical Center, New York, NY
Jeanette Wasserstein, Ph.D.
Mount Sinai Medical Center, New York, NY
4.40
ADHD Comorbidity in a Very Large Private Insurance Claims Database
Alexandre A. Todorov, Ph.D.
Washington University School of Medicine in St. Louis, Saint Louis, MO
Michael T. Lynskey, Ph.D.
Washington University School of Medicine in St. Louis, St Louis, MO
Theodore J. Cicero, Ph.D.
Washington University School of Medicine in St. Louis, St. Louis, MO
Angela M. Reiersen, M.D., M.P.E.
Washington University School of Medicine in St. Louis, Saint Louis, MO
4.41
The Role of Volunteers in Home-Based Child Protection Intervention: Impact on Mental Health of Family Members
Jane E. Akister, Ph.D.
Anglia Ruskin University, Cambridge United Kingdom
Niamh O'Brien, M.S.C.
Anglia Ruskin University, Chelmsford United Kingdom
4.43
Maternal Yelling and the Child Behavior Checklist-Dysregulation Profile
Sarah E. Guth, M.D.
University of Vermont College of Medicine, Burlington, VT
Robert Althoff, M.D., Ph.D.
University of Vermont, Burlington, VT
Matthew Albaugh, B.A.
University of Vermont Center for Children Youth and Families, Burlington, VT
David C. Rettew, M.D.
University of Vermont College of Medicine, Burlington, VT
James J. Hudziak, M.D.
Vermont Center For Children, Youth, and Families, Burlington, VT
4.44
Trauma and Adversity in Children and Teens with Problematic Sexual Behaviours: Comparing an Intellectually Disabled Versus Non-Intellectually Disabled Clinical Sample
Heidi M. Haensel, M.D., FRCPC
Children’s Hospital at London Health Sciences Centre, London, ON
Richard Zayed, Ph.D.
The University of Western Ontario, London, ON
G. Toni Swart, M.D., FRCPC
Child and Parent Resource Institute, London, ON
Mary-Ellen Marshman, M.S.C.
Child and Parent Resource Institute, London, ON
4.45
A Domestic Violence Shelter Parenting Program for Mothers with Young Children
Brooks R. Keeshin, M.D.
Cincinnati Children's Hospital Medical Center, Cincinnati, OH
Amy Oxman, L.C.S.W.
Primary Children's Medical Center, Salt Lake City, UT
Sheryl Schindler, M.S.
University of Utah, Salt Lake City, UT
Kristine Campbell, M.D.
University of Utah, Salt Lake City, UT
4.48
Development of the IWK-Parent-Adolescent Communication Checklist
Anita Unruh, Ph.D.
Dalhousie University, Halifax, NS
Alexa Bagnell, M.D., FRCPC
Izaak Walton Killam Health Centre, Dalhousie University, Halifax, NS
Anna Huguet, Ph.D.
Izaak Walton Killam Health Centre, Dalhousie University, Halifax, NS
Patrick McGrath, Ph.D.
Dalhousie University, Halifax, NS
4.49
Psychological Intervention for Adolescents Diagnosed with Learning Disorders I Can Succeed (ICS): Treatment Model, Feasibility, and Acceptability
Daphne Kopelman-Rubin, Dr.P.H.
Interdisciplinary Center; Schneider Children's Medical Center of Israel, Herzliya Israel
Anat Brunstein Klomek, Ph.D.
Interdisciplinary Center; Schneider Children's Medical Center of Israel, Herzliya Israel
Michal Al-Yagon, Ph.D.
Tel Aviv University, Tel-Aviv Israel
Laura Mufson, Ph.D.
Columbia University; New York State Psychiatric Institute, New York, NY
Alan Apter, M.D.
The Feinberg Child Study Center and Interdisiplinary Center Herzliya, Tel-Aviv University, Petach Tikva Israel
Mario Mikulincer, D. Phil.
Interdisciplinary Center, Herzliya Israel
4.52
Interactive Influences of Serotonin Transporter Gene Variation and Childhood Abuse on Development of Alcohol Abuse/Dependence
Chelsea J. Jin, M.S.
Columbia University, New York, NY
Ping Wu, Ph.D.
Columbia University, New York, NY
Monique Ernst, M.D.
National Institutes of Health, National Institute of Mental Health, Bethesda, MD
Cordelia Fuller, M.S.
New York State Psychiatric Institute, New York, NY
Patricia Cohen, Ph.D.
Columbia University, New York, NY
4.53
A Pilot Study of Lisdexamfetamine Dimesylate for the Treatment of ADHD and Smoking/Nicotine Dependence
Scott H. Kollins, Ph.D.
Duke University Medical Center, Durham, NC
Joseph S. English, M.S.
Duke University Medical Center, Durham, NC
Benjamin O'Brien, B.S.
Duke University Medical Center, Durham, NC
Allan K. Chrisman, M.D.
Duke University Medical Center, Durham, NC
Rachel E. Dew, M.D., M.S.
Duke University Medical Center, Durham, NC
F. Joseph McClernon, Ph.D.
Duke University Medical Center, Durham, NC
4.54
Response Inhibition Among Adolescent Cannabis Users: A Case-Control Study
Javier Goti, M.D.
Neuroscience Institute. Hospital Clinic Barcelona, Barcelona Spain
Laura Aso, M.A.
Neuroscience Institute. Hospital Clinic Barcelona, Barcelona Spain
Rosa Diaz-hurtado, Ph.D.
Neuroscience Institute. Hospital Clinic Barcelona, Barcelona Spain
Olga Puig, Ph.D.
Neuroscience Institute. Hospital Clinic Barcelona, Barcelona Spain
Josefina Castro-Fornieles, M.D., Ph.D.
IDIBAPS, CIBERSAM, Neurosciences Institute, Universitat de Barcelona, Barcelona Spain
4.56
Bath Salt Abuse Leading to Psychosis and Suicidal Ideation: A Case Report
Madhav Muppa, M.D.
Louisiana State University, Shreveport, LA
Sarah M. Wakefield, M.D.
Louisiana State University Health Sciences Center, Shreveport, LA
Lee Stevens, M.D.
Louisiana State University, Shreveport, LA
Carlton Baker, M.B.A.
Brentwood Hospital, Shreveport, LA
4.57
Lifetime Marijuana Use, Gambling, and Health Correlates Among Adolescents
Christopher Hammond, M.D.
Yale Child Study Center, New Haven, CT
Corey Pilver, Ph.D.
Yale University, New Haven, CT
Lori Rugle, Ph.D.
Problem Gambling Services, Middletown, CT
Marvin Steinberg, Ph.D.
Connecticut Council on Problem Gambling, Clinton, CT
Robert Malison, M.D.
Yale University, New Haven, CT
Linda C. Mayes, M.D.
Yale Child Study Center, New Haven, CT
Suchitra Krishnan-Sarin, Ph.D.
Yale School of Medicine, New Haven, CT
Rani A. Desai, Ph.D.
Yale School of Medicine, New Haven, CT
Marc N. Potenza, M.D., Ph.D.
Yale School of Medicine, New Haven, CT
4.58
Substance Dependence and Psychiatric Comorbidity in Young Adults with Bipolar Disorder: Preliminary Findings of an Ongoing Longitudinal Study
Timothy E. Wilens, M.D.
Massachusetts General Hospital, Boston, MA
MaryKate Martelon, M.P.H.
Massachusetts General Hospital, Boston, MA
Joseph Biederman, M.D.
Massachusetts General Hospital, Boston, MA
Jesse Anderson, B.A.
Massachusetts General Hospital, Boston, MA
4.60
A Prospective, 24 Month Study of Open-Label OROS Methylphenidate in the Prevention of Cigarette Smoking in ADHD Youth
Paul Hammerness, M.D.
Massachusetts General Hospital, Cambridge, MA
Robert L. Doyle, M.D.
Harvard Medical School, Boston, MA
Gagan Joshi, M.D.
Massachusetts General Hospital, Boston, MA
Anna Georgiopoulos, M.D.
Harvard Medical School, Boston, MA
Daniel A. Geller, M.D.
Massachusetts General Hospital, Newton, MA
Thomas J. Spencer, M.D.
Massachusetts General Hospital, Boston, MA
Carter R. Petty, M.A.
Massachusetts General Hospital, Boston, MA
Ashley Chilton, B.S.
Massachusetts General Hospital, Cambridge, MA
Stephen V. Faraone, Ph.D.
State University of New York Upstate Medical University, Syracuse, NY
Joseph Biederman, M.D.
Massachusetts General Hospital, Boston, MA
